TKMR Stock UPDATES Tekmira Pharmaceuticals Corp (TKMR) 18.56

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Tekmira Pharmaceuticals Corp (TKMR) 18.56 $TKMR

'Mad Money' Lightning Round: I Still Want to Own Freeport-McMoRan
at The Street - Sat Sep 06, 5:00AM CDT
Cramer likes Take-Two Interactive over Activision Blizzard and if you wanted Tekmira Pharmaceuticals you're too late.

Jim Cramer's 'Mad Money' Recap: Next Week's Game Plan
at The Street - Fri Sep 05, 6:37PM CDT
Cramer is looking for bargains, and that means he'll be watching Yahoo!, Apple and Restoration Hardware next week.

J&J Ebola Vaccine Gets Funding, Development to Pick Pace - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Sep 04, 2:37PM CDT
Johnson & Johnson (JNJ) announced that its Ebola vaccine development process will be fast-tracked.

Technical Data on Biotech Stocks - ARIAD Pharma, Tekmira Pharma, Arrowhead Research, Celgene, and Amgen
PR Newswire - Thu Sep 04, 7:55AM CDT
On Wednesday, September 03, 2014, the NASDAQ Composite ended at 4,572.57, down 0.56%, the Dow Jones Industrial Average finished the day 0.06% higher at 17,078.28, and the S&P 500 closed at 2,000.72, down 0.08%. During the trading session, six out of ten sectors finished on a higher note. The S&P 500 Health Care Sector Index ended the day at 740.75, up 0.41%, with the index advancing 6.93% in the previous three months. Investor-Edge has initiated coverage on the following equities: ARIAD Pharmaceuticals Inc. (NASDAQ: ARIA), Tekmira Pharmaceuticals Corporation (NASDAQ: TKMR), Arrowhead Research Corporation (NASDAQ: ARWR), Celgene Corporation (NASDAQ: CELG), and Amgen Inc. (NASDAQ: AMGN). Free research on these five companies can be accessed at:

BioCryst's Ebola Candidate Moving to Efficacy Study Soon - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Sep 02, 2:08PM CDT
BioCryst 's (BCRX) BCX4430 will be evaluated in a non-human primate study shortly.

Glaxo Up on Accelerated Ebola Vaccine Development Process - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Sep 02, 1:50PM CDT
Glaxo's Ebola vaccine development process has been fast-tracked by an international consortium.

Upcoming Event, Positive Findings, Regulatory Approvals, and Vaccine License - Research Reports on WellPoint, Tekmira, Zoetis, Sanofi and GSK
PR Newswire - Tue Sep 02, 8:00AM CDT
Today, Analysts Review released its research reports regarding WellPoint Inc. (NYSE: WLP), Tekmira Pharmaceuticals Corporation (NASDAQ: TKMR), Zoetis Inc. (NYSE: ZTS), Sanofi SA (NYSE: SNY) and GlaxoSmithKline plc (NYSE: GSK). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/6142-100free.

Nasdaq stocks posting largest percentage increases
AP - Fri Aug 29, 12:19PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at 1 p.m.:

'Fast Money' Recap: When Is the Next Market Correction?
at The Street - Fri Aug 29, 4:00AM CDT
The trading panel discussed when the market will pull back, cyber attacks and the company making Apple's sapphire screens.

Why Tekmira Pharmaceuticals (TKMR) Stock Is Surging Today
at The Street - Thu Aug 28, 10:12AM CDT
Tekmira Pharmaceuticals (TKMR) surged Thursday as takeover talks swirl around the Vancouver-based biotech company.

Why Tekmira Pharmaceuticals (TKMR) Stock Is Gaining Today
at The Street - Thu Aug 21, 9:30AM CDT
Monkeys sickened by Marburg virus, an Ebola relative that kills in the same way and is equally as fatal, survived the disease after being treated with its experimental drug.

Tekmira Pharmaceuticals (TKMR) Is Today's Dead Cat Bounce Stock
at The Street - Thu Aug 21, 8:45AM CDT
Trade-Ideas LLC identified Tekmira Pharmaceuticals (TKMR) as a "dead cat bounce" (down big yesterday but up big today) candidate

The Zacks Analyst Blog Highlights: Johnson & Johnson, Tekmira Pharmaceuticals, GileadSciences, Allergan and Supernus Pharmaceuticals
PR Newswire - Thu Aug 21, 8:30AM CDT
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the Johnson & Johnson (NYSE:JNJ-Free Report), Tekmira Pharmaceuticals Corp (Nasdaq:TKMR-Free Report), Gilead Sciences Inc. (Nasdaq:GILD-Free Report), Allergan Inc. (NYSE:AGN-Free Report) and Supernus Pharmaceuticals, Inc. (Nasdaq:SUPN-Free Report).

Healthcare Enjoys Growth Trends: 3 Medical Stocks to Buy - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Aug 20, 3:27PM CDT
Favorable industry trends in the pharma and bio-tech space makes the healthcare sector a lucrative investment destination.

Tekmira's Lipid Nanoparticle (LNP) Technology Targeting Marburg Virus Highlighted in Scientific Publication
GlobeNewswire - Wed Aug 20, 1:00PM CDT
Tekmira Pharmaceuticals Corporation (Nasdaq:TKMR) (TSX:TKM), a leading developer of RNA interference (RNAi) therapeutics, today announced the publication of data in a peer-reviewed scientific journal which highlights positive results in an animal model of Marburg virus infection enabled by Tekmira's lipid nanoparticle (LNP) technology.

5 Stocks Jumping on Unusual Volume
at The Street - Tue Aug 19, 5:30AM CDT
Often when above-average volume moves into an equity, it precedes a large spike in volatility.

Why Tekmira Pharmaceuticals (TKMR) Stock Is Spiking Today
at The Street - Mon Aug 18, 12:29PM CDT
Tekmira Pharmaceuticals (TKMR) shares are up double digits after having coverage initiated with an 'outperform' rating and $25 price target by analysts at Leerink.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Microencapsulation Market to Hit $24B by 2031

Updated Category News Views 7

Think about wrapping a tiny gift inside a bubble that's not only protective but also dissolves at just the right moment. That, my friends, is microencapsulation summed up—and it's becoming a big deal. With the market poised to jump from $16.90 billion in 2026 to a whopping $24.02 billion by 2031, at a steady clip of 7.3% annually, there's a lot for investors to chew on...

Continue Reading
Phoenix Reveals Cost-Saving Hacks for Transfer Students

Updated Category News Views 3

Making College Cost Manageable Okay, let's get real about college costs. Tuition fees got folks holding their breath tighter than a bull in a bear market. University of Phoenix ain't turning a blind eye—during National Transfer Student Week, they're shouting from the rooftops about pocket-friendly ways to snag that degree without selling your soul or flipping another...

Continue Reading
3D Concrete Printing Set to Transform Construction by 2035

Updated Category News Views 0

Concrete Revolution: The 3D Printing Surge Times are changing in construction, and this ain’t your grandfather’s cinder block. We're talking about 3D concrete printing here—an industry poised to swell from just a pipedream sort of $293.4 million in 2025 to a staggering $1.87 billion by 2035. Driven by housing demands and resilient defense contracts, the sector is...

Continue Reading
Station Casinos Secures $500M Loan Amid Economic Challenges

Updated Category News Views 4

Is Leveraging Debt the Right Move for Station Casinos? Las Vegas just can't stay out of the news, can it? This time, it's all about Station Casinos and their big move to rustle up $500 million in cold, hard cash through an incremental Term B Loan. A move like this ain't exactly playin' it safe, but let's dive deeper into why they're chasing these greenbacks. What's the...

Continue Reading
Doximity Faces Legal Fire: Investor Stakes at Risk

Updated Category News Views 4

Doximity's Legal Storm: A Rocky Road Ahead? Here's the deal, folks. Doximity, a name some might've thrown around in digital health conclaves, is now wrapped up in a mire of legal woes. Those tricky waters come courtesy of a securities class action lawsuit—all about overstated growth prospects that took some investors by surprise. What's Got Investors Peeved? Investors...

Continue Reading
McLean Guide: Turning Culture Data into Real Action

Updated Category News Views 4

Unlocking the Potential of Culture Measurement In the corporate jungle, culture is like oxygen. You don’t see it, but you sure as heck feel it when it’s missing or toxic. McLean & Company just dropped a new guide that promises to map out the invisible by measuring organizational culture. Now, you might say, 'Cultural alignment sounds like consultant mumbo-jumbo.' But...

Continue Reading
YiKEDA™ Shakes Up SIAL Paris 2026 with Tomato Twist

Updated Category News Views 5

YiKEDA™ Steps Onto the Global Scene Tell you what, there's a new player in the beverage sector—and it's shaking things up with a tomato twist! YiKEDA™, the premium Chinese fruit tomato brand, has stomped its way into the limelight at SIAL Paris 2026. From October 17th to 21st, the brand made its grand debut at one of the globe's hotshot food industry exhibitions,...

Continue Reading
qBraid OS Launching Quantum Computing to New Heights

Updated Category News Views 6

Paving a New Era for Quantum Computing That quantum computing isn't just about flashy algorithms anymore. It's about weaving together some downright powerful hardware under a seamless system. Enter qBraid OS, the new kid on the block offering a sprawling interface to drape quantum processors, CPUs, and NVIDIA GPUs over one cohesive operating system. Folks in the thick of...

Continue Reading
Radware Dominates SPARK Matrix™ for Bot Management

Updated Category News Views 5

Why Radware Stands Out in Bot Management Radware has been making quite the splash in the tech world, now sitting pretty as the leader in QKS Group's SPARK Matrix™ for Bot Management in 2026. This isn't just some random pat on the back; it's a recognition of Radware's outstanding execution. Their innovative approach, especially in the realm of cloud application...

Continue Reading
Duolingo Faces Class Action: Investors Brace for Impact

Updated Category News Views 0

Going Beyond Language Learning Hype Listen, it's not every day you wake up to a lawsuit calling out one of those seemingly indestructible tech darlings. Well, Duolingo (NASDAQ: DUOL) is caught in the crosshairs now. They face allegations of pulling the wool over investors' eyes about their monetization and growth tactics. If you snapped up some stock between May 2, 2025,...

Continue Reading

Top 5 Most Recently Viewed Articles

Bitcoin Solaris Launches Phase 5 Presale for Mobile Mining

Updated Category News Views 155

Bitcoin Solaris Enters Phase 5 Presale Bitcoin Solaris, a pioneering decentralized blockchain solution focused on mobile-first mining, has announced its entry into Presale Phase 5. In this phase, BTC-S tokens are priced at just 5 USDT. This strategic move comes right before the launch of a selected group test for the Nova App Beta, which aims to revolutionize the mining...

Continue Reading
Skyhigh Security Achieves Major Success in 2024 Year-End Review

Updated Category News Views 430

Skyhigh Security Marks a Transformative Year in 2024 Skyhigh Security, a recognized leader in the Security Service Edge (SSE) and data security sectors, has successfully navigated 2024, establishing itself as a pivotal player in securing data for organizations operating in a hybrid and regulated landscape. This year, the company emphasized innovation, expanding its global...

Continue Reading
Colorado Approves Tax Increases to Support School Meal Funding

Updated Category News Views 128

Colorado's New Tax Measures for School Meal Access Recently, Colorado voters have made a significant decision to raise taxes for the state’s top earners, all aimed at ensuring that every public school student has access to free meals. This groundbreaking initiative came through two ballot measures approved with substantial margins. Understanding the Measures Proposition...

Continue Reading
Understanding the Growth of General Dynamics Over 5 Years

Updated Category News Views 152

The Incredible Growth of General Dynamics Stock General Dynamics (GD) has shown remarkable growth in the stock market over the past five years. An investment of just $100 made five years ago has now transformed into an impressive sum, reflecting the robust performance and market resilience of this corporation. Returns That Outperform the Market In terms of annualized...

Continue Reading
Embark on Celestial Journeys with Oceania Cruises' Eclipse Sails

Updated Category News Views 113

Witness the Wonders of the Universe with Oceania Cruises Oceania Cruises is preparing to transport guests into the depths of beauty and wonder as they unveil a unique series of sailings dedicated to the 2026 solar eclipse. This event represents a rare opportunity for travelers and astronomy enthusiasts alike, as they can join five exceptional voyages positioned in prime...

Continue Reading